Bispecific Antibodies Are Associated With Progressive Multifocal Leukoencephalopathy
PML represents a rare but serious, life-threatening complication of BisAbs therapy in MM, and should be considered in patients receiving BisAbs therapy who develop new neurologic symptoms, and prompt evaluation is warranted.